Sanofi (SNY)
43.79
0.00 (0.00%)
Upcoming Events
Latest Headlines
Form SCHEDULE 13G/A Sanofi Filed by: Amundi
July 22, 2026 9:50 AM - SEC Filing
Sanofi reshapes executive committee effective September 2026
July 21, 2026 12:05 PM - StreetInsider
Press Release: Sanofi evolves its Executive Committee to support its next strategic chapter
July 21, 2026 12:00 PM - Globe NewsWire
Form 6-K Sanofi For: Jul 17
July 17, 2026 6:04 AM - SEC Filing
US FDA approves Sanofi's wearable injector form of blood cancer drug
July 10, 2026 8:56 AM - StreetInsider
FDA clears Sanofi's Sarclisa Escena via on-body injector for myeloma
July 10, 2026 8:36 AM - StreetInsider
Press Release: Sanofi’s subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector
July 10, 2026 8:35 AM - Globe NewsWire
EU seeks feedback on Sanofi commitments over flu vaccine probe
July 8, 2026 6:02 AM - StreetInsider
Sanofi (SAN:FP) (SNY) PT Lowered to EUR86 at Morgan Stanley
July 8, 2026 4:49 AM - StreetInsider
Form 6-K Sanofi For: Jul 07
July 7, 2026 9:02 AM - SEC Filing
Form 11-K Sanofi For: Dec 31
June 30, 2026 1:28 PM - SEC Filing
Form 11-K Sanofi For: Dec 31
June 30, 2026 12:54 PM - SEC Filing
Form NT 11-K Sanofi For: Dec 31
June 30, 2026 11:49 AM - SEC Filing
Form NT 11-K Sanofi For: Dec 31
June 30, 2026 11:45 AM - SEC Filing
Form 6-K Sanofi For: Jun 24
June 24, 2026 8:44 AM - SEC Filing
Form 6-K Sanofi For: Jun 22
June 22, 2026 8:43 AM - SEC Filing
Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis
June 22, 2026 8:30 AM - StreetInsider
Sanofi (SNY) call put ratio 8.4 calls to 1 put with a focus on July 45 calls
June 22, 2026 6:04 AM - StreetInsider
Press Release: Sanofi appoints Paulo Fontoura as Global Head of R&D
June 22, 2026 2:00 AM - Globe NewsWire
Sanofi wins Japan approval for Sarclisa SC in multiple myeloma
June 19, 2026 6:31 AM - StreetInsider
Press Release: Sanofi’s Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma
June 19, 2026 6:31 AM - Globe NewsWire
Sanofi (SAN:FP) (SNY) PT Lowered to EUR95 at Deutsche Bank
June 15, 2026 5:12 AM - StreetInsider
Press Release: Sanofi’s Tzield approved in the US as the first disease-modifying therapy for patients recently diagnosed with stage 3 type 1 diabetes
June 12, 2026 6:10 PM - Globe NewsWire
Form 6-K Sanofi For: Jun 12
June 12, 2026 11:42 AM - SEC Filing
Guggenheim Defending Dianthus Therapeutics (DNTH): 'We reiterate our positive view'
June 10, 2026 4:10 PM - StreetInsider
TD Cowen Defending Dianthus Therapeutics (DNTH): 'We see weakness as a buying opportunity'
June 10, 2026 1:37 PM - StreetInsider
Raymond James on Dianthus Therapeutics (DNTH) Amid 15% Down Day: 'We See Overall Positive Readthrough to Claseprubart'
June 10, 2026 1:01 PM - StreetInsider
Form 6-K Sanofi For: Jun 08
June 8, 2026 6:07 AM - SEC Filing
Press Release: Sanofi launches 2026 global employee stock purchase plan
June 4, 2026 4:07 AM - Globe NewsWire
Sanofi partners with Snowflake to build AI agent for sales teams
June 2, 2026 9:09 AM - StreetInsider
Form SD Sanofi
May 28, 2026 6:07 AM - SEC Filing
Form 6-K Sanofi For: May 27
May 27, 2026 10:32 AM - SEC Filing
China holds roundtable with over 50 foreign pharmaceutical firms
May 22, 2026 9:54 AM - StreetInsider
China Commerce Ministry holding meeting with foreign pharma companies including Lilly, Sanofi, Novartis, Merck
May 22, 2026 9:24 AM - StreetInsider
Sanofi reports positive phase 2 trial results for AATD treatment
May 18, 2026 3:30 PM - StreetInsider
Press Release: ATS: phase 2 data demonstrate the superiority of efdoralprin alfa over a standard-of-care augmentation therapy in achieving higher fAAT levels in AATD
May 18, 2026 3:30 PM - Globe NewsWire
Form 13F-HR Sanofi For: Mar 31
May 7, 2026 8:47 AM - SEC Filing
Sanofi Supports AlphaDetect to Accelerate Detection of Alpha-1
May 6, 2026 12:42 PM - PR NewsWire
Form 6-K Sanofi For: May 05
May 5, 2026 6:08 AM - SEC Filing
Sanofi expands AI center in Toronto with $294 million investment
May 4, 2026 1:02 PM - StreetInsider
Morgan Stanley Downgrades Sanofi (SNY) to Equalweight
May 1, 2026 3:39 PM - StreetInsider
Sanofi names Belén Garijo as CEO following shareholder approval
April 29, 2026 12:00 PM - StreetInsider
Press Release: Annual General Meeting of April 29, 2026 - Belén Garijo appointed as Director and Chief Executive Officer of Sanofi
April 29, 2026 12:00 PM - Globe NewsWire
Regeneron beats first quarter estimates on Dupixent strength
April 29, 2026 6:55 AM - StreetInsider
Form 6-K Sanofi For: Apr 29
April 29, 2026 6:11 AM - SEC Filing
Form 6-K Sanofi For: Apr 27
April 27, 2026 12:58 PM - SEC Filing
Sanofi drug gets EU panel backing for progressive multiple sclerosis
April 24, 2026 6:10 AM - StreetInsider
Press Release: Sanofi’s Cenrifki (tolebrutinib) recommended for EU approval by the CHMP to treat secondary progressive multiple sclerosis without relapses
April 24, 2026 6:09 AM - Globe NewsWire
Full Article List
